MAURA MINEO: Open Payments
NPI 1225716558 · BUTLER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,376 in 234 payments from 20 companies in 2025. Trend: 2023 $1,904 · 2024 $3,332 · 2025 $5,376
Food & beverage: $5,376
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 31 | $947 |
| GlaxoSmithKline, LLC. | 33 | $714 |
| GENZYME CORPORATION | 20 | $669 |
| CSL Behring | 26 | $571 |
| ARS Pharmaceuticals Operations, Inc. | 25 | $558 |
| Regeneron Healthcare Solutions, Inc. | 20 | $390 |
| Novartis Pharmaceuticals Corporation | 23 | $349 |
| BioCryst US Sales Co., LLC | 18 | $279 |
| Genentech USA, Inc. | 7 | $206 |
| Grifols USA, LLC | 3 | $186 |
Products named: DUPIXENT, NEFFY, TEZSPIRE, NUCALA, Andembry, AIRSUPRA, Xolair, ORLADEYO.
Industry payments across PA — which companies pay providers there.
